Overview
- Royal Philips said it will publish its formal 2026 outlook on February 10 and has not provided any early guidance.
- Management reiterated expectations for sequential comparable-sales acceleration in 2026 toward mid-single-digit growth, expanded margins, and strong cash generation despite tariff pressure.
- After cautious remarks by CEO Roy Jakobs at Citi’s Global Healthcare Conference, Reuters reported the company is unlikely to reach the 4.5% consensus organic growth target for 2026.
- Citi analysts warned tariff headwinds are expected to almost double next year and described a mixed hospital-capex backdrop with muted demand in China.
- Shares fell about 5.3% on Thursday, the biggest single-day drop since February, even after Q3 results beat EPS estimates and matched sales expectations.